Latest Stories
Featured Stories
Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.
Feedback
All Stories
Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.
Hamad Alam
Rectal Adenocarcinoma
New Delhi
Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…
Shilipi
Acute Recurrent Pancreatitis
Kotdwar, Uttarakhand.
Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …
Anurag Goyal
Investment Banker
New Delhi
Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…
Sumit Kumar
Pancreas Divisum with secondary Chronic Pancreatitis
Dehradun, Uttarakhand
Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…
Aviral Saxena
Chronic Pancreatitis with Secondary Diabetes
Dehradun, Uttarakhand
Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …
Rajeev Sharma
Chronic Pancreatitis
Dehradun, Uttarakhand
Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…
Research
Our Research
At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.
CA19-9 lowering effect of Ayurvedic Mineral Complex in the patients of Chronic Pancreatitis
CA19-9, a marker for pancreatic cancer, is elevated in pancreatitis and some gastrointestinal cancers. An Ayurvedic Mineral Complex (AMC) has shown promise in lowering CA19-9 levels in pancreatitis patients. This finding could lead to further research on AMC as a preventive therapy for pancreatic cancer in such patients. This study reports on 43 pancreatitis patients treated with AMC.
Significant Reduction of Carbohydrate 19-9 Antigen Levels in a Patient of Acute on Chronic Pancreatitis through Ayurvedic Treatment Protocol
A 52-year-old male with recurrent acute necrotizing pancreatitis showed poor response to conventional treatment, leading to weight loss and high CA 19-9 levels. Ayurvedic therapy, including herbal formulations, a balanced diet, and rest, normalized his CA 19-9 levels within 108 days, highlighting its potential for further study.
Scientific validated approach for application of Mandura bhasma A review
Mandura (iron rust) is purified and calcined in Ayurveda to create Mandura Bhasma, used for conditions like spleen and liver enlargement, jaundice, oedema, and anemia. Our study found that Prak-20 aligns with the classical dose schedule for Mandura Bhasma.
Acute and Sub acute Toxicity Study of Ayurvedic Formulation (AYFs) Used for Migraine Treatment
This study tested the safety of five Ayurvedic formulations for migraine prevention in rats and mice. Acute and sub-acute toxicity studies showed no toxic effects at doses up to 10 times the human dose. A slight mortality in high-dose groups was unrelated to treatment. The formulations are considered safe, but further chronic toxicity studies are needed.
Case studies on prophylactic ayurvedic therapy in migraine patients
Ayurvedic treatment has shown effectiveness in managing migraines. A protocol (ATP) with herbo-mineral formulations, regular meals, and sleep reduced migraine frequency and intensity in a study of nine patients. Five reported significant improvement after 120 days, with no serious side effects. Ongoing research is further validating the findings.
Hepato-protective Effect of an Ayurvedic Formulation Prak-20 in CCl 4 Induced Toxicity in Rats: Results of Three Studies
Prak-20, an ayurvedic herbo-mineral formulation, was studied for its hepato-protective effects in rats. It showed no significant liver damage or elevated enzyme levels compared to controls. In higher doses, it reduced liver enzymes by up to 54% and minimized liver damage. These results suggest Prak-20 is effective in protecting the liver, with further research needed on its mechanism.